BCI
LKFT

Brinker Capital Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Brinker Capital Investments’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Buy
+7,426
New +$246K ﹤0.01% 1809
2025
Q4 		– Sell
-7,261
Closed -$252K – 2134
2025
Q3 		$252K Buy
+7,261
New +$232K ﹤0.01% 1858

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brinker Capital Investments's LKFT Position: Q1 2026 in Review

Brinker Capital Investments opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 7,426 shares worth $223K. The stake represents ﹤0.01% of the portfolio and ranks #1809 among its holdings. This is a return to the name: Brinker Capital Investments previously reported a position in LKFT as recently as Q3 2025.

Brinker Capital Investments first reported a position in LKFT in Q3 2025 and has held it in 2 quarters since. The position peaked at $252K in Q3 2025. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Brinker Capital Investments held 7,426 shares of Lakefront Biotherapeutics American Depositary Shares worth $223K as of Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Brinker Capital Investments position in Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #1809 holding.
  • Brinker Capital Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2025 and has held it in 2 quarters since.
  • Brinker Capital Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $252K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.